title: The contribution of proinsulin and des-31,32 proinsulin to the hyperinsulinemia of diabetic and nondiabetic cirrhotic patients.
abstract: We used specific, monoclonal antibody-based, two-site immunoradiometric assays to test the hypothesis that serum levels of proinsulin and des-31,32 proinsulin would be increased in cirrhosis, particularly in those with overt diabetes. A 75-g oral glucose tolerance test was performed after an overnight fast in eight cirrhotic patients with diabetes (fasting blood glucose, 7.8 +/- 2.2 [SE] mmol/L), seven nondiabetic cirrhotic patients, and eight normal control subjects. Fasting serum immunoreactive insulin levels were approximately six times higher in cirrhotics than in controls, but were not different between diabetic and nondiabetic cirrhotic patients. After oral glucose, the incremental area under the serum insulin concentration curve was 3,475 +/- 1,009 pmol.L-1.h in nondiabetic cirrhotic patients, significantly higher than in controls (761 +/- 48, P < .001) or diabetic cirrhotic patients (881 +/- 186, P < .05). Fasting serum proinsulin levels in diabetic cirrhotic patients (24.0 +/- 5.7 pmol/L) were higher than in controls (2.3 +/- .05, P < .001) or nondiabetic cirrhotic patients (4.4 +/- 0.8, P < .005). Fasting serum levels of des-31,32 proinsulin were also much higher in diabetic cirrhotic patients than in nondiabetic cirrhotic patients or controls (P < .02 and P < .005, respectively). Fasting proinsulin plus des-31,32 proinsulin constituted 12.5% +/- 1.4% of serum immunoreactive insulin in diabetic cirrhotics, higher than in nondiabetic cirrhotics (3.7% +/- 0.5%, P < .001) and normal controls (7.8% +/- 1.5%, P = .035).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, Royal Postgraduate Medical School, London, UK.
authors.forename: Y T
authors.initials: YT
authors.lastname: Kruszynska
authors.forename: D S
authors.initials: DS
authors.lastname: Harry
authors.forename: V
authors.initials: V
authors.lastname: Mohamed-Ali
authors.forename: P D
authors.initials: PD
authors.lastname: Home
authors.forename: J S
authors.initials: JS
authors.lastname: Yudkin
authors.forename: N
authors.initials: N
authors.lastname: McIntyre
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism*; D005215:Fasting; D005951:Glucose Tolerance Test; D006801:Humans; D007118:Immunoassay; D007328:Insulin / Q000378:metabolism*; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications / Q000378:metabolism*; D008875:Middle Aged; D011384:Proinsulin / Q000097:blood*; D011498:Protein Precursors / Q000097:blood*
chemical_list: D000911:Antibodies, Monoclonal; D007328:Insulin; D011498:Protein Precursors; C070703:proinsulin, des(31,32)-; D011384:Proinsulin